Evaluation of Potential Product Interactions

Consumers frequently do not tell their health providers about their use of CAHP, health providers often fail to ask about the use of such products (13), and most of the purchases of these products occur outside a pharmacy— all of these factors enhance the likelihood of adverse product interactions and make detection of such interactions much more difficult. 

MedWatch is an umbrella program developed by the FDA to enhance the reporting of serious adverse events by health professionals, which are suspected to be related to the use of FDA-regulated products (www.fda.gov/ 

---